IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Curis Lifesciences IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Swastika Investmart is the merchant banker of Curis Lifesciences IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st December 2024.
Curis Lifesciences IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].Curis Lifesciences IPO size is Rs [●] crores with IPO price of Rs [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Swastika Investmart Limited is the book-running lead manager of the Curis Lifesciences IPO. Link Intime India Private Limited is the Registrar and Market Maker is [●] for Curis Lifesciences IPO.
Curis Lifesciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Curis Lifesciences IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on . The company is launching its SME UPCOMING IPO on the NSE EMERGE exchange, using the Book Building Issue method. Curis Lifesciences IPO size is ₹ [●] Crores with fresh issue size of Rs [●] Crores and Offer for sale being Nil.
The IPO allotment date for Curis Lifesciences IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Curis Lifesciences IPO allotment status on the registrars website, Link Intime India Private Limited. Curis Lifesciences IPO refund dates are [●].
Curis Lifesciences IPO is expected to be listed on [●].
The upper price band for the Curis Lifesciences IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Curis Lifesciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Curis Lifesciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Curis Lifesciences IPO is finalised.
The merchant banker for Curis Lifesciences IPO is Swastika Investmart Limited . Swastika Investmart Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Curis Lifesciences IPO RHP for further details.
The registrar for Curis Lifesciences IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Curis Lifesciences IPO through their official website or helpline.
Curis Lifesciences IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
[●]
Sector: Pharmaceutical
SME IPO so far:
34
Merchant Banker:
Swastika Investmart
SME IPO by BRLM so far:
47
City:
Ahmedabad
SME IPO so far:
30
Revenue (annualised):
₹ 36.44 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: [●]
Curis Lifesciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Curis Lifesciences Financial Review Page
Merchant Banker(s) of Curis Lifesciences IPO: Swastika Investmart Limited
Curis Lifesciences IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Curis Lifesciences IPO listed at a listing price of against the offer price of .
The current market price of Curis Lifesciences is .
Why Us?
